SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARESE, Mattia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.286
EU - Europa 2.900
AS - Asia 2.148
SA - Sud America 298
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 63
OC - Oceania 3
Totale 8.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.184
FI - Finlandia 1.922
SG - Singapore 791
CN - Cina 540
IT - Italia 277
VN - Vietnam 234
BR - Brasile 231
DE - Germania 159
HK - Hong Kong 157
GB - Regno Unito 93
PL - Polonia 75
JP - Giappone 71
FR - Francia 67
ID - Indonesia 67
TR - Turchia 67
UA - Ucraina 65
CA - Canada 53
RU - Federazione Russa 47
SE - Svezia 47
BD - Bangladesh 46
IN - India 43
MX - Messico 34
AR - Argentina 27
NO - Norvegia 22
PK - Pakistan 22
IQ - Iraq 19
ES - Italia 18
NL - Olanda 18
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
BE - Belgio 15
EC - Ecuador 12
IR - Iran 12
KE - Kenya 11
AT - Austria 10
VE - Venezuela 10
MA - Marocco 9
SA - Arabia Saudita 9
IE - Irlanda 8
LT - Lituania 8
MY - Malesia 8
UZ - Uzbekistan 8
CL - Cile 7
KR - Corea 7
CO - Colombia 6
DK - Danimarca 6
IL - Israele 6
PT - Portogallo 6
AZ - Azerbaigian 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
GE - Georgia 4
PH - Filippine 4
TH - Thailandia 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
JO - Giordania 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
CR - Costa Rica 2
GT - Guatemala 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.696
Salva come PNG Salva come JPEG
Città #
Helsinki 1.907
Singapore 515
Ashburn 392
San Jose 243
Chandler 212
Fairfield 195
Santa Clara 195
Beijing 177
Hong Kong 149
Woodbridge 131
Council Bluffs 123
Dallas 120
Ferrara 113
New York 99
Seattle 90
Houston 82
Ho Chi Minh City 80
Los Angeles 72
Wilmington 71
Warsaw 69
Cambridge 67
Ann Arbor 64
Tokyo 61
Jakarta 57
Munich 57
Hanoi 56
Izmir 47
Princeton 44
Shanghai 44
Jacksonville 43
Nanjing 37
São Paulo 35
Dearborn 34
Lauterbourg 33
Milan 32
Bremen 22
Denver 21
Orem 21
Toronto 20
Chicago 18
Brooklyn 16
London 16
Montreal 16
Oslo 16
Mexico City 15
Moscow 15
Nanchang 15
Atlanta 14
Boardman 14
Phoenix 14
Poplar 14
Brno 13
Guangzhou 13
Falkenstein 12
Lahore 12
Redwood City 12
Rio de Janeiro 12
San Diego 12
The Dalles 12
Da Nang 11
Rome 11
Bologna 10
Brussels 10
Dong Ket 10
Manchester 10
Shenyang 10
Hebei 9
Johannesburg 9
Tianjin 9
Baghdad 8
Frankfurt am Main 8
Haiphong 8
Jiaxing 8
Nairobi 8
San Francisco 8
Buffalo 7
Chennai 7
Kyiv 7
Mumbai 7
Stockholm 7
Tashkent 7
Turku 7
Washington 7
Zhengzhou 7
Amsterdam 6
Boston 6
Copenhagen 6
Fairford 6
Indore 6
Kunming 6
Nuremberg 6
Piemonte 6
Quito 6
Santiago 6
Andover 5
Belo Horizonte 5
Curitiba 5
Ferrara di Monte Baldo 5
Florence 5
Jinan 5
Totale 6.411
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.054
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 312
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 311
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 248
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 247
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 236
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 224
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 215
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 213
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 207
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 204
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 188
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 185
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 182
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 180
Protein engineering and pharmacological approaches to develop novel treatment strategies for coagulation disorders 180
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 175
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 174
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 169
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 167
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 166
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 164
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 162
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 162
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 158
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 158
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 157
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 157
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 157
An advanced method for the small-scale production of high-quality minicircle DNA 155
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 146
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 145
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 140
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 133
Next generation factor VIIa with enhanced half-life 123
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains 106
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 105
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 96
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 94
null 93
Totale 8.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022299 0 35 8 4 21 22 5 12 17 31 21 123
2022/2023436 48 61 12 62 62 50 30 31 42 5 18 15
2023/2024285 10 23 16 4 17 61 15 30 6 9 12 82
2024/20251.124 36 20 97 29 130 167 20 23 178 103 181 140
2025/20265.031 299 181 229 415 460 222 374 183 2.138 329 126 75
2026/2027157 67 90 0 0 0 0 0 0 0 0 0 0
Totale 8.848